2024 Q1 Form 10-Q Financial Statement
#000149315224010340 Filed on March 18, 2024
Income Statement
Concept | 2024 Q1 |
---|---|
Revenue | $19.54M |
YoY Change | 6.63% |
Cost Of Revenue | $16.06M |
YoY Change | 0.34% |
Gross Profit | $3.480M |
YoY Change | 49.99% |
Gross Profit Margin | 17.81% |
Selling, General & Admin | $2.690M |
YoY Change | -8.55% |
% of Gross Profit | 77.29% |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $154.5K |
YoY Change | 10.19% |
% of Gross Profit | 4.44% |
Operating Expenses | $2.863M |
YoY Change | -8.26% |
Operating Profit | $616.9K |
YoY Change | -177.02% |
Interest Expense | $117.5K |
YoY Change | -9.91% |
% of Operating Profit | 19.05% |
Other Income/Expense, Net | -$123.6K |
YoY Change | -221.52% |
Pretax Income | $493.4K |
YoY Change | -170.55% |
Income Tax | $142.3K |
% Of Pretax Income | 28.85% |
Net Earnings | $351.0K |
YoY Change | -165.97% |
Net Earnings / Revenue | 1.8% |
Basic Earnings Per Share | $0.06 |
Diluted Earnings Per Share | $0.06 |
COMMON SHARES | |
Basic Shares Outstanding | 5.709M shares |
Diluted Shares Outstanding | 5.709M shares |
Balance Sheet
Concept | 2024 Q1 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $2.408M |
YoY Change | -43.41% |
Cash & Equivalents | $2.408M |
Short-Term Investments | |
Other Short-Term Assets | $493.5K |
YoY Change | 53.99% |
Inventory | $17.01M |
Prepaid Expenses | $310.9K |
Receivables | $8.070M |
Other Receivables | $1.663M |
Total Short-Term Assets | $29.65M |
YoY Change | -0.31% |
LONG-TERM ASSETS | |
Property, Plant & Equipment | $3.348M |
YoY Change | 2.4% |
Goodwill | |
YoY Change | |
Intangibles | $327.0K |
YoY Change | 0.0% |
Long-Term Investments | $33.65K |
YoY Change | -90.37% |
Other Assets | $1.390M |
YoY Change | -14.32% |
Total Long-Term Assets | $7.931M |
YoY Change | -28.6% |
TOTAL ASSETS | |
Total Short-Term Assets | $29.65M |
Total Long-Term Assets | $7.931M |
Total Assets | $37.58M |
YoY Change | -8.0% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $4.446M |
YoY Change | 2.22% |
Accrued Expenses | $563.5K |
YoY Change | 201.51% |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $0.00 |
YoY Change | |
Long-Term Debt Due | $4.704M |
YoY Change | 111904.76% |
Total Short-Term Liabilities | $10.75M |
YoY Change | 107.71% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $2.070K |
YoY Change | -99.98% |
Other Long-Term Liabilities | $2.765M |
YoY Change | -16.7% |
Total Long-Term Liabilities | $2.767M |
YoY Change | -76.26% |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $10.75M |
Total Long-Term Liabilities | $2.767M |
Total Liabilities | $13.51M |
YoY Change | -19.71% |
SHAREHOLDERS EQUITY | |
Retained Earnings | $9.843M |
YoY Change | 0.49% |
Common Stock | $6.634K |
YoY Change | 0.0% |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | $4.634M |
YoY Change | 0.0% |
Treasury Stock Shares | |
Shareholders Equity | $24.31M |
YoY Change | |
Total Liabilities & Shareholders Equity | $37.58M |
YoY Change | -8.0% |
Cashflow Statement
Concept | 2024 Q1 |
---|---|
OPERATING ACTIVITIES | |
Net Income | $351.0K |
YoY Change | -165.97% |
Depreciation, Depletion And Amortization | $154.5K |
YoY Change | 10.19% |
Cash From Operating Activities | $4.595M |
YoY Change | 63.9% |
INVESTING ACTIVITIES | |
Capital Expenditures | |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | |
YoY Change | |
Cash From Investing Activities | |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | -$4.921M |
YoY Change | 470.39% |
NET CHANGE | |
Cash From Operating Activities | $4.595M |
Cash From Investing Activities | |
Cash From Financing Activities | -$4.921M |
Net Change In Cash | -$326.1K |
YoY Change | -118.76% |
FREE CASH FLOW | |
Cash From Operating Activities | $4.595M |
Capital Expenditures | |
Free Cash Flow | $4.595M |
YoY Change | 76.62% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2024Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2024Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--10-31 | |
CY2024Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001007019 | |
CY2024Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
usd | |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
|
usd | |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
|
usd | |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
usd | |
CY2024Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
usd | |
CY2023Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
usd | |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
usd | |
CY2024Q1 | us-gaap |
Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
|
usd | |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | |
CY2024Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2024Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2024Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-01-31 | |
CY2024Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | |
CY2024Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2024Q1 | dei |
Entity File Number
EntityFileNumber
|
001-32491 | |
CY2024Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Coffee Holding Co., Inc. | |
CY2024Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2024Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
11-2238111 | |
CY2024Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
3475 Victory Boulevard | |
CY2024Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Staten Island | |
CY2024Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
NY | |
CY2024Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
10314 | |
CY2024Q1 | dei |
City Area Code
CityAreaCode
|
(718) | |
CY2024Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
832-0800 | |
CY2024Q1 | dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | |
CY2024Q1 | dei |
Trading Symbol
TradingSymbol
|
JVA | |
CY2024Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2024Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2024Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2024Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2024Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2024Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2024Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2024Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
5708599 | shares |
CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2407863 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2733977 | usd |
CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
144000 | usd |
CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
144000 | usd |
CY2024Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
8070427 | usd |
CY2023Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
7983032 | usd |
CY2024Q1 | us-gaap |
Receivable Investment Sale
ReceivableInvestmentSale
|
450000 | usd |
CY2023Q4 | us-gaap |
Receivable Investment Sale
ReceivableInvestmentSale
|
3150000 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
17012265 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
18986539 | usd |
CY2024Q1 | us-gaap |
Due From Correspondent Brokers
DueFromCorrespondentBrokers
|
902120 | usd |
CY2023Q4 | us-gaap |
Due From Correspondent Brokers
DueFromCorrespondentBrokers
|
345760 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
493519 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
413752 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
310906 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
365876 | usd |
CY2024Q1 | us-gaap |
Assets Current
AssetsCurrent
|
29647100 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
33978936 | usd |
CY2024Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3347607 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3494450 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
318008 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
310383 | usd |
CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
177125 | usd |
CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
184750 | usd |
CY2024Q1 | us-gaap |
Indefinite Lived Trademarks
IndefiniteLivedTrademarks
|
327000 | usd |
CY2023Q4 | us-gaap |
Indefinite Lived Trademarks
IndefiniteLivedTrademarks
|
327000 | usd |
CY2024Q1 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
33652 | usd |
CY2023Q4 | us-gaap |
Equity Method Investments
EquityMethodInvestments
|
39676 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2655799 | usd |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2696159 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1254056 | usd |
CY2023Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1341407 | usd |
CY2024Q1 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
136162 | usd |
CY2023Q4 | us-gaap |
Deposits Assets Noncurrent
DepositsAssetsNoncurrent
|
129523 | usd |
CY2024Q1 | us-gaap |
Assets
Assets
|
37578501 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
42191901 | usd |
CY2024Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
4446339 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
5206442 | usd |
CY2024Q1 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
4700000 | usd |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
9620000 | usd |
CY2024Q1 | us-gaap |
Due To Correspondent Brokers
DueToCorrespondentBrokers
|
1031605 | usd |
CY2023Q4 | us-gaap |
Due To Correspondent Brokers
DueToCorrespondentBrokers
|
292407 | usd |
CY2024Q1 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
4200 | usd |
CY2023Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
4200 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
563474 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
255625 | usd |
CY2024Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10745618 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
15378674 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2637535 | usd |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2974579 | usd |
CY2024Q1 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
2071 | usd |
CY2023Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
3034 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
127162 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
120523 | usd |
CY2024Q1 | us-gaap |
Liabilities
Liabilities
|
13512386 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
18476810 | usd |
CY2024Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | shares |
CY2024Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6633930 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6633930 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5708599 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5708599 | shares |
CY2024Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
6634 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
6634 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19094618 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
19094618 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
9842885 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
9491861 | usd |
CY2024Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
925331 | shares |
CY2023Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
925331 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
4633560 | usd |
CY2023Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
4633560 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24310577 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
23959553 | usd |
CY2024Q1 | us-gaap |
Minority Interest
MinorityInterest
|
-244462 | usd |
CY2023Q4 | us-gaap |
Minority Interest
MinorityInterest
|
-244462 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24066115 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
23715091 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
37578501 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
42191901 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
19540402 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18326114 | usd |
CY2024Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
16060103 | usd |
CY2023Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
16005814 | usd |
CY2024Q1 | us-gaap |
Gross Profit
GrossProfit
|
3480299 | usd |
CY2023Q1 | us-gaap |
Gross Profit
GrossProfit
|
2320300 | usd |
CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2690047 | usd |
CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2941437 | usd |
CY2024Q1 | us-gaap |
Officers Compensation
OfficersCompensation
|
173341 | usd |
CY2023Q1 | us-gaap |
Officers Compensation
OfficersCompensation
|
179888 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
2863388 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3121325 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
616911 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-801025 | usd |
CY2024Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
7 | usd |
CY2023Q1 | us-gaap |
Interest Income Other
InterestIncomeOther
|
3107 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-6024 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-5017 | usd |
CY2023Q1 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
234041 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
117533 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
130459 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-123550 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
101672 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
493361 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-699353 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
142337 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-167250 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
351024 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-532103 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
351024 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-532103 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.06 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.06 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.09 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.09 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5708599 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5708599 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5708599 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5708599 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24550667 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-532103 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24018564 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
23715091 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
23715091 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
351024 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
351024 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24066115 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
24066115 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
351024 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-532103 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
154468 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
140188 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
|
-182838 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
|
772021 | usd |
CY2024Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-6024 | usd |
CY2023Q1 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-5017 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
82322 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
79663 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
87351 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-167250 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2612605 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-915609 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-1974274 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-2555433 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
79767 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-111636 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
|
-54970 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-71157 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-67699 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-760103 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
535039 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
4594849 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
2803512 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
202018 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-202018 | usd |
CY2024Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
14404 | usd |
CY2023Q1 | us-gaap |
Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
|
914782 | usd |
CY2023Q1 | us-gaap |
Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
|
-876148 | usd |
CY2024Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
963 | usd |
CY2023Q1 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1373 | usd |
CY2024Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
4934404 | usd |
CY2023Q1 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
900000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-4920963 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-862739 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-326114 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
1738755 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2733977 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2515873 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2407863 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
4254628 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
141945 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
121019 | usd |
CY2024Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
|
41962 | usd |
CY2023Q1 | us-gaap |
Noncash Or Part Noncash Acquisition Other Assets Acquired1
NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1
|
40797 | usd |
CY2024Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_80E_eus-gaap--NatureOfOperations_zHYxZb5heM0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_823_ztgzRmb7azeg">BUSINESS ACTIVITIES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Coffee Holding Co., Inc. (the “Company”) conducts wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. The Company’s core product, coffee, can be summarized and divided into three product categories (“product lines”) as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Wholesale Green Coffee:</i></b> unroasted raw beans imported from around the world and sold to large and small roasters and coffee shop operators;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private Label Coffee:</i></b> coffee roasted, blended, packaged and sold under the specifications and names of others, including supermarkets that want to have their own brand name on coffee to compete with national brands; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Branded Coffee:</i></b> coffee roasted and blended to the Company’s own specifications and packaged and sold under the Company’s eight proprietary and licensed brand names in different segments of the market.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s private label and branded coffee sales are primarily to customers that are located throughout the United States with limited sales in Canada and certain countries in Asia. Such customers include supermarkets, wholesalers, and individually-owned and multi-unit retailers. The Company’s unprocessed green coffee, which includes over 90 specialty coffee offerings, is sold primarily to specialty gourmet roasters and to coffee shop operators in the United States with limited sales in Australia, Canada, England and China.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholesale green, private label, and branded coffee product categories generate revenues and cost of sales individually but incur selling, general and administrative expenses in the aggregate. There are no individual product managers and discrete financial information is not available for any of the product lines. The Company’s product portfolio is used in one business and it operates and competes in one business activity and economic environment. In addition, the three product lines share customers, manufacturing resources, sales channels, and marketing support. Thus, the Company considers the three product lines to be one single reporting segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 29, 2022, the Company entered into a Merger and Share Exchange Agreement (the “Merger Agreement”), by and among the Company, Delta Corp Holdings Limited, a Cayman Islands exempted company (“Pubco”), Delta Corp Holdings Limited, a company incorporated in England and Wales (“Delta”), CHC Merger Sub Inc., a Nevada corporation and wholly owned subsidiary of Pubco (“Merger Sub”), and each of the holders of ordinary shares of Delta as named therein (the “Sellers”). Upon the terms and subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company, with the Company surviving as a direct, wholly-owned subsidiary of Pubco (the “Merger”). As a result of the Merger, each issued and outstanding share of the Company common stock, $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220929__us-gaap--TypeOfArrangementAxis__custom--MergerAgreementMember_zPCIbkgndzQ6" title="Common stock, par value">0.001</span> par value per share (the “Common Stock”), will be cancelled and converted for the right of the holder thereof to receive one ordinary share, par value $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220929__srt--TitleOfIndividualAxis__custom--PubcoMember_zIIXsiv3lQwa" title="Common stock, par value">0.0001</span> of Pubco (the “Pubco Ordinary Shares”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going Concern</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October 31, 2023, the Company’s line of credit of $<span id="xdx_903_eus-gaap--LinesOfCreditCurrent_iI_pn5n6_c20231031_zbsK3lOMZDca" title="Line of credit">9.6</span> million becomes due in June 2024, for which the Company will seek to obtain a renewal of the financing arrangement. There were certain financial covenants that the Company is in violation. The Company has not received a waiver from the lender. The lender has reserved its rights and remedies at any time in its sole discretion. As of January 31, 2024, the Company is back in compliance with those financial covenants, however there are uncertainties surrounding the ability to receive a waiver and extending its line of credit when becomes due. These uncertainties raise substantial doubt as to whether existing cash and cash equivalents will be sufficient to meet its obligations as they become due within twelve months from the date the consolidated financial statements were issued, The current balance outstanding as of March 6, 2024 is $<span id="xdx_901_eus-gaap--LinesOfCreditCurrent_iI_pn5n6_c20240306__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXF4b1FJ5qt2" title="Line of credit">4.7</span> million. The Company continues to expand its customer base, which is expected to increase margins and profitability in future periods. However, there can be no assurance of such continued success.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COFFEE HOLDING CO., INC.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JANUARY 31, 2024 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | |
CY2023Q4 | us-gaap |
Lines Of Credit Current
LinesOfCreditCurrent
|
9600000 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
19540402 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18326114 | usd |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
19540402 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
18326114 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
17012265 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
18986539 | usd |
CY2024Q1 | us-gaap |
Inventory Net
InventoryNet
|
17012265 | usd |
CY2023Q4 | us-gaap |
Inventory Net
InventoryNet
|
18986539 | usd |
CY2024Q1 | us-gaap |
Derivative Gain On Derivative
DerivativeGainOnDerivative
|
567694 | usd |
CY2023Q1 | us-gaap |
Derivative Gain On Derivative
DerivativeGainOnDerivative
|
128925 | usd |
CY2024Q1 | us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
34823 | usd |
CY2023Q1 | us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
666050 | usd |
CY2024Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-182836 | usd |
CY2023Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
772021 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
350035 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
234896 | usd |
CY2024Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
350035 | usd |
CY2023Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
234896 | usd |
CY2024Q1 | us-gaap |
Line Of Credit
LineOfCredit
|
4700000 | usd |
CY2023Q4 | us-gaap |
Line Of Credit
LineOfCredit
|
9620000 | usd |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5708599 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5708599 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5708599 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5708599 | shares |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2655799 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2832907 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
563474 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
186879 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2637535 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3142959 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3201009 | usd |
CY2023Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3329838 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
82322 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
79663 | usd |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P10Y | |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P10Y | |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.049 | pure |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.049 | pure |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
697345 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
400868 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
376683 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
367788 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
305648 | usd |
CY2024Q1 | JVA |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
2027652 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
4175984 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
974975 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3201009 | usd |
CY2024Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
56851 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
127162 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
120523 | usd |
CY2024Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
|
0 | usd |
CY2023Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
|
0 | usd |